| | Muscle spasms for NCT01217749 @en | |
| | Adjusted Mean Change From Base ...... 8 Baseline (Week 0) and Week 8 @en | |
| | eligibility for clinicaltrials:NCT00192504 @en | |
| | negative pregnancy test for women able to have children @en | |
| | Abdominal Cramps for NCT00935493 @en | |
| | Number of Participants With Ov ...... e last dose of study treatment @en | |
| | eligibility for clinicaltrials:NCT00002392 @en | |
| | Overall response rate of initi ...... in Part 1 (approx. 5 months). @en | |
| | 7-day point prevalence smoking ...... ntion (8 weeks after baseline) @en | |
| | concurrent chemoradiotherapy plus DC-CIK immunotherapy @en | |
| | | |
| | No prior New York Heart Association class I-IV heart disease @en | |
| | | |
| | serum creatinine ≤ 1.5×ULN or Creatinine clearance ≥ 60 mL/min @en | |
| | | |
| | | |
| | Hemoglobin < 12.0 g/dL @en | |
| | Stephen Robinson, FRCP, MD @en | |
| | Antibody Concentrations Agains ...... 3rd vaccine dose i.e. Month 5 @en | |
| | Chemotherapy/Cell
...... al to 1.6 mg/dl. (Turnstile II @en | |
| | Time to Last Unformed Stool (TTLUS) 48 hours @en | |
| | 6-month Progression-free Survival 6 months after first dose @en | |
| | Myocardial infarction for NCT00878800 @en | |
| | Alcohol poisoning for NCT00492063 @en | |
| | Fungal infection for NCT00460798 @en | |
| | HAMD-17 total score at week 8. Tolerability. at week 8 @en | |
| | | |
| | Asthenia for NCT00833638 @en | |
| | Persistance and adherence to treatment 2 years @en | |
| | Daily GC (prednisone or deflazacort) therapy for > 12 months @en | |
| | | |
| | Pyelonephritis for NCT01183013 @en | |
| | clinicaltrials:NCT00955383 study design @en | |
| | Abnormal electrocardiogram wit ...... QRS; or atrial fibrillation); @en | |
| | clinical results for clinicaltrials:NCT01660763 @en | |
| | Modified Mayo Score indicating remission Week 12 and Week 24 @en | |
| | eligibility for clinicaltrials:NCT01514175 @en | |
| | (2)Fatty liver was diagnosed b ...... another gastrologist @en | |
| | | |
| | | |
| | Voluntary consent before performance of any study-related procedure @en | |
| | eligibility for clinicaltrials:NCT01629108 @en | |
| | Subunit or killed vaccines within 14 days prior to enrollment. @en | |
| | Lymphopenia for NCT01001221 @en | |
| | | |
| | | |
| | | |
| | Maximum Reading Speed Month 12 @en | |
| | Prostate cancer diagnosed with prostate biopsy @en | |
| | Blood and lymphatic system disorders - Other for NCT00028002 @en | |